Chronic Myelogenous LeukemiaThis page contains recent news articles, when available, and an overview of Chronic Myelogenous Leukemia but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.
News: Chronic Myelogenous Leukemia
Examiner.comFormer basketball and movie star, Kareem Abdul Jabbar, announced today that he has been diagnosed with a rare form of leukemia. ...
Kareem Abdul-Jabbar suffering from cancer: chronic myelogenous leukemia - Nov 11, 2009
Examiner.comAP Photo/Josh Reynolds file Karim Abdul Jabbar has announced that he has been undergoing treatment for cancer, specifically chronic myelogenous leukemia. ...
Kim Eyes Rooting Out Leukemia - Nov 15, 2009
Korea TimesIn chronic myelogenous leukemia, tyrosine kinase is active. Imatinib attaches to the problem, and prevents the enzyme's activity. ...
Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 - Nov 18, 2009
RTT News (press release)...and BCR-ABL in chronic myelogenous leukemia. In preclinical studies, inhibiting Hsp90 causes the degradation of these proteins and cancer cell death. ...
China Medical Technologies Receives SFDA Approval for its Leukemia BCR/ABL ... - Nov 9, 2009
CNNMoney.com (press release)...abnormality associated with chronic myelogenous leukemia ("CML"), acute lymphoblastic leukemia ("ALL") and acute myelogenous leukemia ("AML"). ...
China Medical Wins Approval for Leukemia FISH Probe - Nov 10, 2009
Seeking Alpha (blog)...selecting the different treatment protocols appropriate for chronic myelogenous leukemia, acute lymphoblastic leukemia and acute myelogenous leukemia. ...
AACR: Conference Offers Look at Cancer Drugs in Pipeline International ... - Nov 18, 2009
ModernMedicineOf 4000 small molecules screened, etoposide showed promise in acute myeloid leukemia and chronic myelogenous leukemia, and ciclopirox olamine and kinetin ...
TV news reporter hopes to inspire with new book - Nov 9, 2009
Montgomery NewspapersA year later he was assigned to cover the story of Hawaii resident Chris Pablo, who just weeks after being diagnosed with chronic myelogenous leukemia, ...
Stem Cell Therapy International, Inc. and Histostem Korea Announce Providing ... - Nov 5, 2009
CNNMoney.com (press release)The first Hong Kong patient will be treated for Chronic Myelogenous Leukemia. We have a significant opportunity to distribute our stem cells to patients ...
Novartis Says Weak IP Protection Makes India R&D Impossible - Nov 13, 2009
Seeking Alpha (blog)Gleevec has, however, become the standard of care for treatment of chronic myelogenous leukemia, gastrointestinal stromal tumors and certain other ...
Leukemia Research Presented At International Symposium - Nov 11, 2009
PressZoom (press release)...in identifying and developing Gleevec as an oral treatment for chronic myelogenous leukemia that has strikingly improved the survival for such patients. ...
Teenager's death hits Blake hard - Oct 29, 2009
Globe and MailTwo years ago, Leafs forward Jason Blake was new to the team and the city and struggling to deal with the news he had chronic myelogenous leukemia, ...
MolecularMD Establishes New Operations Facility to Support Growth in ... - Nov 1, 2009
PR-CANADA.net (press release)...the development of targeted cancer therapies specifically with respect to CML (chronic myelogenous leukemia) and GIST (gastrointestinal stromal tumor). ...
Immigrant Detainees Staging Hunger Strikes to Protest Deplorable ... - 07 Aug 2009
AlterNetJuan Marin Corona is a detainee and human rights monitor at the South Louisiana Correctional Center, where chronic myelogenous leukemia and diabetes are
Finding Key To Cancer Drug Gleevec's Limitations - Aug 5, 2009
Science Daily (press release)It is also called chronic granulocytic leukemia or chronic myelogenous leukemia. An estimated 5050 men and women will be diagnosed with chronic myeloid
Gender and ethnic differences in chronic myelogenous leukemia ... - Jul 24, 2009
7thSpace Interactive (press release)Our study was undertaken to examine the demographic and clinical features of chronic myelogenous leukemia (CML) patients presenting initially at the LAC+USC
Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma ... - Jul 30, 2009
PR Newswire (press release) (press release)In 1973, Dr. Rowley showed that the Philadelphia Chromosome associated with chronic myelogenous leukemia (CML) was an abnormal translocation of two
Janet Rowley to receive Presidential Medal of Freedom for cancer ... - Jul 30, 2009
Genetic Engineering News (press release) (press release)They found that patients with chronic myelogenous leukemia had an abnormally small chromosome 22 in their tumor cells, which they labeled the "Philadelphia"
Recruitment, red tape and costs thwart efficacy of many cancer studies - Aug 2, 2009
San Jose Mercury NewsOf course, there have been successful clinical trials — studies of drugs like Gleevec for chronic myelogenous leukemia and estrogen-blocking therapy for
Undergraduate Researchers Discover Job Opportunities at Amgen ... - Jul 22, 2009
Imperial Valley NewsFor the past three years, Ho has studied chronic myelogenous leukemia. She also has been making monetary donations to the American Cancer Society and
ASU grad shares gift of life with others - Jul 18, 2009
East Valley TribuneJoe Cajic was reliving the most difficult part of life with Chronic Myelogenous Leukemia. It wasn't the 187000 white blood cells collapsing his body.
Without a bone marrow donor, I wouldn't be here today - Jul 15, 2009
McGuire Air Force BaseAfter the results came back, the oncologist informed me that I was in the blast phase of chronic myelogenous leukemia - the last and most dangerous phase of
Gleevec shows promise as targeted melanoma treatment - Jul 27, 2009
Gerson Lehrman Group...with mutations in the KIT oncogene, Philadelphia chromosome positive chronic myelogenous leukemia and KIT+ GIST (gastrointestinal stromal tumors).
Teacher who inspired legions of support dies - Jul 17, 2009
Merced Sun-Star...prepared to travel to Stanford University where she would undergo a bone marrow transplant to cure the mother of two from chronic myelogenous leukemia.
Ryan O'Neal: I Hit On My Daughter Tatum At Farrah's Funeral - Aug 4, 2009
Celebritygossip.ieDespite their split, they eventually managed to come back together when O'Neal was diagnosed with chronic myelogenous leukemia in 2001 (it has since been
Top 10 Worst NHL Contracts - Jul 15, 2009
My NHL Trade RumorsIt should be noted that Blake has had health issues (a rare but treatable form of cancer- chronic myelogenous leukemia) and has played as hard as anyone
The Maker of a Miracle Drug - Dec 24, 2008
BusinessWeekHe knew that a rare form of cancer called chronic myelogenous leukemia (CML) is caused by a rearrangement of genes that, in turn, results in a faulty enzyme
Novartis, Glaxo to unveil new data at conference - Dec 5, 2008
CNNMoney.comNovartis also is presenting two midstage studies of its already-approved drug Tasigna as an initial treatment for people with chronic myelogenous leukemia
Christ the King's Vinny Casiano refuses to let leukemia keep him ... - Dec 2, 2008
New York Daily News,BY EBENEZER SAMUEL CK junior Vinny Casiano returns to gridiron on Oct. 11, less than two months after being diagnosed with chronic myelogenous leukemia.
CML Patient Survey Shows That Side Effects Are A Serious Issue And ... - Dec 8, 2008
Canada NewsWire (press release),8 /CNW Telbec/ - Startling findings from a new CML (chronic myelogenous leukemia) patient survey were presented at a satellite meeting of the American
More Than 200 Abstracts at ASH and SABCS Reveal Potential ... - Dec 3, 2008
MarketWatch...for the treatment of newly diagnosed adult patients with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in the chronic phase.
Novartis reports positive results from two Phase II studies of ... - Dec 9, 2008
Trading Markets (press release),Approximately 73 patients with newly diagnosed Ph+ chronic myelogenous leukemia (CML) in early chronic phase are enrolled in the trial.
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy ... - Dec 8, 2008
SYS-CON Media,...chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy that included imatinib.
First Genome Of Cancer Patient Sequenced By Researchers - Dec 14, 2008
TopCancerNews.com,...says Brian Druker, MD, whose research helped identify the targeted drug Gleevec as a promising therapy for chronic myelogenous leukemia.
Targeted Therapies and Effective Management of Patients With ... - Dec 5, 2008
MedscapeOutline key mechanisms of resistance to targeted therapies for patients with gastrointestinal stromal tumors (GIST) or chronic myelogenous leukemia (CML).
Novartis International AG (VTX:NOVN) Tasigna® Demonstrates Rapid ... - Dec 11, 2008
ABN Newswire (press release),Tasigna is indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome-positive chronic myelogenous leukemia in adult
Exelixis Reports Positive Phase 1 Data for XL228 at ASH Annual Meeting - Dec 8, 2008
WELT ONLINE,Exelixis, Inc. (Nasdaq:EXEL) today reported preliminary phase 1 data from a dose-escalation trial of XL228 in patients with chronic myelogenous leukemia
Clinical Trial Demonstrates Safety Of Pre-transplant Expansion Of ... - Dec 8, 2008
Science Daily (press release)Patients with recurrent, high-risk acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous leukemia, many types of lymphoma, aplastic anemia
Asian American Bone Marrow Donor Program Expands to Include Latinos - Dec 14, 2008
New America Media,Last June, Ochoa, 24, was diagnosed with acute lymphoblastic leukemia and chronic myelogenous leukemia. When his family learned of his condition,
California Institute for Regenerative Medicine, Invitrogen ... - Dec 12, 2008
Cell Based Assay News,They also used the screen to dig up a handful of genes involved in chronic myelogenous leukemia cell response to Novartis’ Gleevec (imatinib).
Second-Generation CML Drugs Show Promise as Frontline Therapy - Dec 9, 2008
PharmaLive.com (press release),8, 2008 – Two drugs approved as fallback therapy for chronic myelogenous leukemia (CML) appear to outperform historical benchmarks of the frontline
Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic ... - Dec 5, 2008
PR-Inside.com (Pressemitteilung),Life Science Analytics´, "Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute
Battling cancer with diplomacy, not force - Dec 14, 2008
Daytona Beach News-Journal,In chronic myelogenous leukemia we can now erase the message that is a result of miscommunication between two segments of DNA with a single pill -- Gleevec.
More than 200 abstracts at ASH and SABCS reveal potential ... - Dec 6, 2008
PR-USA.net (press release),Tasigna is indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome-positive chronic myelogenous leukemia in adult
Mesothelioma.com: MD Anderson Cancer Center & Bristol - Dec 3, 2008
TransWorldNews (press release),Dasatinib is also manufactured under the name Sprycel, is administered orally and has been successful in patients with chronic myelogenous leukemia.
Exelixis Reveals New Phase I Data Of XL019 Demonstrating Evidence ... - Dec 7, 2008
RTT News,...include polycythemia vera, essential thrombocytosis, primary or idiopathic myelofibrosis and chronic myelogenous leukemia.
Background information on Chronic Myelogenous Leukemia [When available]
Chronic myelogenous leukemia (or CML) is a form of chronic leukemia characterised by increased production of myeloid cells in the bone marrow. The overwhelming majority is due to a characteristic chromosomal translocation termed the Philadelphia chromosome. It is traditionally treated with chemotherapy, interferon and bone marrow transplantation, although a specific inhibitor (imatinib mesylate) has radically changed the management.
Search the web for more resources on Chronic Myelogenous Leukemia
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines
The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy